Dopamine receptor antagonist with adrenoceptor blocking activity; metabolite of clocapramine, q.v. Prepn: C. Tashiro, I. Horii, US 4337260 (1982 to Yoshitomi); C. Tashiro et al., Yakugaku Zasshi 109, 93 (1989), C.A. 112, 35749j (1990). X-ray crystallographic analysis: I. Ueda, C. Tashiro, Acta Crystallogr. C40, 422 (1984). Receptor binding studies: M. Setoguchi et al., Eur. J. Pharmacol. 112, 313 (1985). Pharmacokinetics and metabolism: J. Ishigooka et al., Psychopharmacology 97, 303 (1989). Toxicity data: H. Horizoe et al., Oyo Yakuri 37, 529 (1989); C.A. 111, 167174g (1989). HPLC determn in plasma: K. Hikida et al., Anal. Sci. 6, 367 (1990).
Antipsychotic.
Antipsychotic; Other Tricyclics; Dopamine Receptor Antagonist